In the U.S., Alzheimer's clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data.
(Image credit: Richard Bailey/Getty Images)
from News : NPR https://ift.tt/2ql8K7F
No comments:
Post a Comment